Concepedia

A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS)

Ellen Warner, Rajesh Kumar Goel, J. Chang, Warren Chow, Shalini Verma, Janet Dancey, E. Franssen, Hélène Dulude, Michael P. Girouard, João Correia,

British Journal of Cancer · 1998 · 34 citations · 15 references

DOIFull text

Open access

Concepts

References

15

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

A. Hilary Calvert, David R. Newell, Lindsey Gumbrell et al. · Journal of Clinical Oncology · 1989 · 1.9K citations

, , +17

Creatinine Clearance: Bedside Estimate

Roger W. Jelliffe · Annals of Internal Medicine · 1973 · 494 citations

, , +17

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.

James L. Abbruzzese, M C Abbruzzese, Renato Lenzi et al. · Journal of Clinical Oncology · 1995 · 321 citations

, , +17

Chronic daily administration of oral etoposide--a phase I trial.

John D. Hainsworth, David H. Johnson, Sheryl Redlin Frazier et al. · Journal of Clinical Oncology · 1989 · 150 citations

, , +15

Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.

John D. Hainsworth, Joan B. Erland, Leonard Kalman et al. · Journal of Clinical Oncology · 1997 · 134 citations

, , +17